{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:12:52Z","timestamp":1760181172908,"version":"build-2065373602"},"reference-count":19,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T00:00:00Z","timestamp":1609286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Eccrine porocarcinoma is a rare aggressive cutaneous malignancy. Complete surgical excision is the standard of care, although there are high rates of local and distant recurrence. We present a unique case of locally recurrent and metastatic subungal porocarcinoma successfully treated with intralesional interleukin-2.<\/jats:p>","DOI":"10.3390\/curroncol28010024","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T04:55:31Z","timestamp":1611032131000},"page":"220-225","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Resolution of Metastatic Subungal Eccrine Porocarcinoma Treated with Intralesional Interleukin-2"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7505-4829","authenticated-orcid":false,"given":"Ashley","family":"Drohan","sequence":"first","affiliation":[{"name":"QEII Health Sciences Centre, Division of General Surgery, Dalhousie University, 1276 South Park St., Halifax, NS B3H 2Y9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Melvin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dalhousie University, QEII Bethune Building, 1276 South Park St., Halifax, NS B3H 2Y9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carman","family":"Giacomantonio","sequence":"additional","affiliation":[{"name":"Department of Surgery, Dalhousie University, Halifax, NS B3H 2Y9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Helyer","sequence":"additional","affiliation":[{"name":"Department of Surgery, Dalhousie University, Halifax, NS B3H 2Y9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Rongioletti, F., M\u0103rg\u0103ritescu, I., and Smoller, B.R. (2015). Rare Malignant Skin Tumors, Springer.","DOI":"10.1007\/978-1-4939-2023-5"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijscr.2016.10.051","article-title":"Porocarcinoma: A systematic review of literature with a single case report","volume":"30","author":"Salih","year":"2017","journal-title":"Int. J. Surg. Case Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/ijd.12714","article-title":"Eccrine porocarcinoma: Epidemiologic and histopathologic characteristics","volume":"54","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/DSS.0000000000001566","article-title":"Eccrine Porocarcinoma","volume":"44","author":"Nazemi","year":"2018","journal-title":"Dermatol. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/DSS.0000000000000763","article-title":"Treatment of Porocarcinoma With Mohs Micrographic Surgery","volume":"42","author":"Tolkachjov","year":"2016","journal-title":"Dermatol. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/1346-8138.12977","article-title":"Metastatic eccrine porocarcinoma successfully treated with carboplatin and epirubicin chemotherapy","volume":"42","author":"Fukuda","year":"2015","journal-title":"J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejca.2017.11.009","article-title":"Complete response of a metastatic porocarcinoma treated with paclitaxel, cetuximab and radiotherapy","volume":"90","author":"Godillot","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archderm.1992.01680180123020","article-title":"Successful Therapy of Metastatic Eccrine Poroma Using Perilesional Interferon Alfa and Interleukin 2","volume":"128","author":"Dummer","year":"1992","journal-title":"Arch. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e12830","DOI":"10.1111\/dth.12830","article-title":"Successful treatment of porocarcinoma with maxacalcitol and imiquimod","volume":"32","author":"Nagasawa","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/DSS.0000000000000389","article-title":"Intralesional Photodynamic Therapy for Eccrine Porocarcinoma","volume":"41","author":"Torchia","year":"2015","journal-title":"Dermatol. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1111\/ijd.12928","article-title":"In-transit metastasis of advanced eccrine porocarcinoma","volume":"54","author":"Imafuku","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cbpa.2014.09.006","article-title":"Use of enhanced interleukin-2 formulations for improved immunotherapy against cancer","volume":"23","author":"Bouchaud","year":"2014","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/cncr.23552","article-title":"High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma","volume":"113","author":"Klapper","year":"2008","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.1999.17.7.2105","article-title":"High-Dose Recombinant Interleukin 2 Therapy for Patients with Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993","volume":"17","author":"Atkins","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1158\/1078-0432.CCR-08-0116","article-title":"Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines","volume":"14","author":"Smith","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1245\/s10434-014-4199-z","article-title":"Pathologic Complete Response to Intralesional Interleukin-2 Therapy Associated with Improved Survival in Melanoma Patients with In-Transit Disease","volume":"22","author":"Hassan","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1517\/14712598.2016.1157161","article-title":"Intralesional immunotherapy as a strategy to treat melanoma","volume":"16","author":"Nouri","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/DSS.0000000000001123","article-title":"Subungual Eccrine Porocarcinoma","volume":"43","author":"Palleschi","year":"2017","journal-title":"Dermatol. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/ijd.13458","article-title":"A fleshy growth below the nail plate in an elderly man","volume":"56","author":"Bhari","year":"2017","journal-title":"Int. J. Dermatol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/1\/24\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:48:07Z","timestamp":1760179687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/1\/24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,30]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["curroncol28010024"],"URL":"https:\/\/doi.org\/10.3390\/curroncol28010024","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2020,12,30]]}}}